JC: Improving Mental Health Among Colombian and Venezuelan Youth Affected by Forced Displacement

Sponsor
Boston College (Other)
Overall Status
Active, not recruiting
CT.gov ID
NCT05857722
Collaborator
Brown University (Other), Universidad de Los Andes (Other)
297
1
2
12.4
24

Study Details

Study Description

Brief Summary

The goal of this randomized controlled trial is to test the effectiveness of an emotion regulation intervention called Jóvenes Capibara in a Venezuelan migrant and internally displaced population sample of youth between the ages of 18 through 30 delivered within a 10-day boot-camp entrepreneurship program. The main questions it aims to answer are: (a) Is Jóvenes Capibara feasible and acceptable among IDP and Venezuelan migrant youth aged 18-30 in Colombia?; (b) Is delivery of Jóvenes Capibara within entrepreneurship training feasible and acceptable among facilitators?; (c) Is Jóvenes Capibara associated with improved mental health, daily functioning, and labor market outcomes in Colombian and Venezuelan youth who receive the YRI compared with control youth? Participants will receive a 10-day intervention, which consists of an entrepreneurship program, plus Jóvenes Capibara, an intervention that aims to improve emotion regulation and mental health symptoms among youth impacted by violence. Measures will be taken at baseline, post-intervention, and at 6-month post-intervention follow-up. The comparison group will receive the intervention one year after youth in the experimental condition. The researchers will compare the experimental group and the waitlist control group to determine the effects of Jóvenes Capibara on mental health, daily functioning, and labor market outcomes.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Jóvenes Capibara
N/A

Detailed Description

The investigators will recruit and enroll 120 male/120 female youth (N=240) aged 18-30 from several communities in Bogotá using stratified selection for gender balance; and then randomize youth to receive the YRI within entrepreneurship training (N=120) or to a waitlist condition (N=120). Waitlisted youth will be eligible to receive the intervention after 6-month follow-up data collection. A codified set of randomization rules will minimize contamination risks, and a computer-generated randomization allocation sequence will guide randomization procedures.

Measures, Data Points, and Data Analysis Strategy: The investigators will collect quantitative data on mental health and daily functioning at baseline, post-intervention, and 6-month follow-up. The investigators will collect qualitative and quantitative data at post-intervention from YRI facilitators and supervisors on implementation outcomes (feasibility, acceptability, adoption, appropriateness). The investigators will use the Difficulties in Emotion Regulation Scale (DERS), General Self-Efficacy Scale, WHO Disability Assessment Schedule (WHODAS), Patient Health Questionnaire (PHQ-9), Generalized Anxiety Disorder Screener (GAD-7), PTSD Checklist-Civilian Version (PCL-C), and the Demographic and Household Scale IPV items (DHS-IPV). The investigators will also assess labor market outcomes, including employment, hours worked, and income earned at each time point. A subset of youth (n=24) selected based on a multivariate sampling matrix will complete exit interviews to assess YRI feasibility, acceptability and satisfaction.

The investigators will use mixed linear effects modeling to investigate the clinical effectiveness of the YRI on mental and behavioral health outcomes among youth. The investigators will compare YRI participants to those in the control condition to assess whether there is significantly greater change in mental health, emotion regulation, daily functioning, and labor market outcomes over time among YRI participants. The investigators will use mixed effects linear models to assess the impact of the intervention on quantitative mental health outcomes. These models will account for clustering of individual outcomes among lay health workers delivering the YRI as well clustering of outcomes within individuals across time points. In cases where the outcome scale scores are skewed and violate the normality assumption for linear models, the investigators will use generalized linear models with a Poisson distribution. The investigators will include a time dummy variable to account for time effects and treatment by time interaction terms to test the impact of the treatment on outcomes at post-intervention and 6-month follow-up. All analyses will be conducted on an intent-to-treat basis.

Power considerations will assess our primary hypothesis -YRI youth will report significantly greater mental health benefits than control youth. The investigators assume a standardized mean difference between intervention and control conditions of approximately 0.30-0.45 to determine YRI effectiveness on youth mental health outcomes, which corresponds to the effect sizes observed in our prior studies. Assuming a standard alpha level of <0.05 with data from 2 time points with a moderate intra-class (within individual) correlation of approximately 0.5, and accounting for 20% attrition, this RCT has power of 0.80 to detect a standardized medium effect size of approximately 0.35.

Study Design

Study Type:
Interventional
Actual Enrollment :
297 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Intervention Model Description:
The investigators will recruit and enroll 120 male/120 female youth (N=240) aged 18-30 from several communities in Bogotá using stratified selection for gender balance; and then randomize youth to receive the YRI within entrepreneurship training (N=120) or to a waitlist condition (N=120). Waitlisted youth will be eligible to receive the intervention after 6-month follow-up data collection.The investigators will recruit and enroll 120 male/120 female youth (N=240) aged 18-30 from several communities in Bogotá using stratified selection for gender balance; and then randomize youth to receive the YRI within entrepreneurship training (N=120) or to a waitlist condition (N=120). Waitlisted youth will be eligible to receive the intervention after 6-month follow-up data collection.
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
Improving Mental Health Among Colombian and Venezuelan Youth Affected by Forced Displacement
Actual Study Start Date :
Mar 21, 2023
Anticipated Primary Completion Date :
Nov 30, 2023
Anticipated Study Completion Date :
Mar 31, 2024

Arms and Interventions

Arm Intervention/Treatment
Experimental: Entrepreneurship and Jóvenes Capibara group

Participants in the experimental arm will receive a 10-day intervention, which consists of an entrepreneurship program, plus Jóvenes Capibara, an intervention that aims to improve emotion regulation and mental health symptoms among youth impacted by violence.

Behavioral: Jóvenes Capibara
Jóvenes Capibara is a 10-session group intervention that was culturally adapted from the Youth Readiness Intervention, which was originally developed in Sierra Leone for conflict-affected youth. Jóvenes Capibara was adapted to the Colombian context using the ADAPT-ITT framework, which ensured that the intervention was relevant to the needs of Colombian and Venezuelan youth.
Other Names:
  • Youth Readiness Intervention
  • Other: Control waitlist condition

    Participants in the control waitlist condition will will be eligible to receive the intervention after 6-month follow-up data collection, which will take place approximately 10 to 12 months after the Entrepreneurship and Jóvenes Capibara group receives the intervention.

    Behavioral: Jóvenes Capibara
    Jóvenes Capibara is a 10-session group intervention that was culturally adapted from the Youth Readiness Intervention, which was originally developed in Sierra Leone for conflict-affected youth. Jóvenes Capibara was adapted to the Colombian context using the ADAPT-ITT framework, which ensured that the intervention was relevant to the needs of Colombian and Venezuelan youth.
    Other Names:
  • Youth Readiness Intervention
  • Outcome Measures

    Primary Outcome Measures

    1. Difficulties in Emotion Regulation Scale (DERS) [Baseline]

      18-item scale that measures emotion regulation using a 1-5 Likert scale. Lower scores indicate worse emotion regulation.

    2. Difficulties in Emotion Regulation Scale (DERS) [Immediately post-intervention]

      18-item scale that measures emotion regulation using a 1-5 Likert scale. Lower scores indicate worse emotion regulation.

    3. Difficulties in Emotion Regulation Scale (DERS) [6 month follow-up: up to 8 months post-baseline]

      18-item scale that measures emotion regulation using a 1-5 Likert scale. Lower scores indicate worse emotion regulation.

    4. World Health Organization Disability Assessment Schedule (WHODAS) [Baseline]

      36-item scale that measures self-rated disability using a 5 point Likert scale ranging from 1 (none) to 5 (extremely or cannot do it). Higher scores indicate higher levels of disability.

    5. World Health Organization Disability Assessment Schedule (WHODAS) [Immediately post-intervention]

      36-item scale that measures self-rated disability using a 5 point Likert scale ranging from 1 (none) to 5 (extremely or cannot do it). Higher scores indicate higher levels of disability.

    6. World Health Organization Disability Assessment Schedule (WHODAS) [6 month follow-up: up to 8 months post-baseline]

      36-item scale that measures self-rated disability using a 1-5 point Likert scale ranging from 1 (none) to 5 (extremely or cannot do it). Higher scores indicate higher levels of disability.

    7. Patient Health Questionnaire (PHQ-9) [Baseline]

      9-item depression scale. This scale uses a 0-3 Likert scale. Lower levels indicate fewer symptoms of depression.

    8. Patient Health Questionnaire (PHQ-9) [Immediately post-intervention]

      9-item depression scale. This scale uses a 0-3 Likert scale. Lower levels indicate fewer symptoms of depression.

    9. Patient Health Questionnaire (PHQ-9) [6 month follow-up: up to 8 months post-baseline]

      9-item depression scale. This scale uses a 0-3 Likert scale. Lower levels indicate fewer symptoms of depression.

    10. Generalized Anxiety Disorder Screener (GAD-7) [Baseline]

      7-item anxiety scale. This scale uses a 0-3 Likert scale, with 0 being "not at all", and 3 being "nearly every day". Lower levels indicate fewer symptoms of anxiety.

    11. Generalized Anxiety Disorder Screener (GAD-7) [Immediately post-intervention]

      7-item anxiety scale. This scale uses a 0-3 Likert scale, with 0 being "not at all", and 3 being "nearly every day". Lower levels indicate fewer symptoms of anxiety.

    12. Generalized Anxiety Disorder Screener (GAD-7) [6 month follow-up: up to 8 months post-baseline]

      7-item anxiety scale. This scale uses a 0-3 Likert scale, with 0 being "not at all", and 3 being "nearly every day". Lower levels indicate fewer symptoms of anxiety.

    13. Post-traumatic stress disorder Checklist-Civilian Version (PTSD CL) [Baseline]

      17-item post-traumatic stress scale. This scale uses a 1-5 Likert scale, with 1 being "Not at all" and 5 being "Extremely". Lower scores indicate fewer symptoms of post-traumatic stress.

    14. Post-traumatic stress disorder Checklist-Civilian Version (PTSD CL) [Immediately post-intervention]

      17-item post-traumatic stress scale. This scale uses a 1-5 Likert scale, with 1 being "Not at all" and 5 being "Extremely". Lower scores indicate fewer symptoms of post-traumatic stress.

    15. Post-traumatic stress disorder Checklist-Civilian Version (PTSD CL) [6 month follow-up: up to 8 months post-baseline]

      17-item post-traumatic stress scale. This scale uses a 1-5 Likert scale, with 1 being "Not at all" and 5 being "Extremely". Lower scores indicate fewer symptoms of post-traumatic stress.

    16. General Self-Efficacy Scale [Baseline]

      10-item self-efficacy scale. This scale uses a 1-4 Liker scale, with 1 being "Not at all true", and 4 being "Exactly true". Lower scores indicate lower levels of self-efficacy.

    17. General Self-Efficacy Scale [Immediately post-intervention]

      10-item self-efficacy scale. This scale uses a 1-4 Liker scale, with 1 being "Not at all true", and 4 being "Exactly true". Lower scores indicate lower levels of self-efficacy.

    18. General Self-Efficacy Scale [6 month follow-up: up to 8 months post-baseline]

      10-item self-efficacy scale. This scale uses a 1-4 Liker scale, with 1 being "Not at all true", and 4 being "Exactly true". Lower scores indicate lower levels of self-efficacy.

    19. Demographic and Household Scale Intimate Partner Violence (DHS-IPV) [Baseline]

      19-36 item questionnaire. The number of items asked depends on the number of questions endorsed. The answers are Yes [1] or No [0]. The first 5 questions are asked to everyone and they do not have skip patterns. Questions 6-35 are asked and if the answer is yes, a follow-up question is asked; otherwise, the question follow-up question is skipped. Lower levels indicate lower levels of intimate partner violence

    20. Demographic and Household Scale Intimate Partner Violence (DHS-IPV) [Immediately post-intervention]

      19-36 item questionnaire. The number of items asked depends on the number of questions endorsed. The answers are Yes [1] or No [0]. The first 5 questions are asked to everyone and they do not have skip patterns. Questions 6-35 are asked and if the answer is yes, a follow-up question is asked; otherwise, the question follow-up question is skipped. Lower levels indicate lower levels of intimate partner violence

    21. Demographic and Household Scale Intimate Partner Violence (DHS-IPV) [6 month follow-up: up to 8 months post-baseline]

      19-36 item questionnaire. The number of items asked depends on the number of questions endorsed. The answers are Yes [1] or No [0]. The first 5 questions are asked to everyone and they do not have skip patterns. Questions 6-35 are asked and if the answer is yes, a follow-up question is asked; otherwise, the question follow-up question is skipped. Lower levels indicate lower levels of intimate partner violence

    22. Labor market outcomes [Baseline]

      Labor market outcomes are measured using a validated scale developed in Colombia. It consists of 21 questions. Questions 1-4 are Yes [1], No [2] questions. If Yes is answered on these questions, then questions 5-19 are asked. Otherwise, questions 5-19 are skipped and asked questions 20 and 21. This questionnaire asks about type of employment, number of hours worked, number of days worked within the past month, occupation, and income.

    23. Labor market outcomes [Immediately post-intervention]

      Labor market outcomes are measured using a validated scale developed in Colombia. It consists of 21 questions. Questions 1-4 are Yes [1], No [2] questions. If Yes is answered on these questions, then questions 5-19 are asked. Otherwise, questions 5-19 are skipped and asked questions 20 and 21. This questionnaire asks about type of employment, number of hours worked, number of days worked within the past month, occupation, and income.

    24. Labor market outcomes [6 month follow-up: up to 8 months post-baseline]

      Labor market outcomes are measured using a validated scale developed in Colombia. It consists of 21 questions. Questions 1-4 are Yes [1], No [2] questions. If Yes is answered on these questions, then questions 5-19 are asked. Otherwise, questions 5-19 are skipped and asked questions 20 and 21. This questionnaire asks about type of employment, number of hours worked, number of days worked within the past month, occupation, and income.

    Secondary Outcome Measures

    1. Family Care Indicators (FCI) [Baseline]

      12-item questionnaire. 6 items are follow-up items to the stem question (even number questions). If the stem question is endorsed, then the follow-up question is asked. Stem question has two answers; Yes [1], No [0]. The follow-up questions ask who engaged the child on a certain activity (i.e., mother, father, other). Lower scores indicate worse child engagement outcomes.

    2. Family Care Indicators (FCI) [Immediately post-intervention]

      12-item questionnaire. 6 items are follow-up items to the stem question (even number questions). If the stem question is endorsed, then the follow-up question is asked. Stem question has two answers; Yes [1], No [0]. The follow-up questions ask who engaged the child on a certain activity (i.e., mother, father, other). Lower scores indicate worse child engagement outcomes.

    3. Family Care Indicators (FCI) [6 month follow-up: up to 8 months post-baseline]

      12-item questionnaire. 6 items are follow-up items to the stem question (even number questions). If the stem question is endorsed, then the follow-up question is asked. Stem question has two answers; Yes [1], No [0]. The follow-up questions ask who engaged the child on a certain activity (i.e., mother, father, other). Lower scores indicate worse child engagement outcomes.

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years to 30 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    Yes
    Inclusion Criteria:
    • Youth aged 18-30

    • Venezuelan migrant or Colombian who has been internally displaced or directly/indirectly impacted by internal conflict in Colombia

    Exclusion Criteria:
    • Current suicidality or homicidality

    • Psychosis

    • Serious medical condition, or severe cognitive impairment that would preclude ability to participate in study assessments and activities, as assessed via the MINI-SCID by a study psychologist.

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Open recruitment Bogotá Colombia

    Sponsors and Collaborators

    • Boston College
    • Brown University
    • Universidad de Los Andes

    Investigators

    None specified.

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Maria Pineros Leano, Assistant Professor, Boston College
    ClinicalTrials.gov Identifier:
    NCT05857722
    Other Study ID Numbers:
    • 27332
    First Posted:
    May 15, 2023
    Last Update Posted:
    May 15, 2023
    Last Verified:
    May 1, 2023
    Individual Participant Data (IPD) Sharing Statement:
    Undecided
    Plan to Share IPD:
    Undecided
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Keywords provided by Maria Pineros Leano, Assistant Professor, Boston College
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of May 15, 2023